Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal disorder with a variable disease course. The recent advancement of antifibrotic therapy has increased the need for reliable and specific biomarkers. This study aimed to assess alveolar epithelial biomarkers as predictors for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Kimiyuki, Chiba, Hirofumi, Nishikiori, Hirotaka, Azuma, Arata, Kondoh, Yasuhiro, Ogura, Takashi, Taguchi, Yoshio, Ebina, Masahito, Sakaguchi, Hiroki, Miyazawa, Shogo, Suga, Moritaka, Sugiyama, Yukihiko, Nukiwa, Toshihiro, Kudoh, Shoji, Takahashi, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706186/
https://www.ncbi.nlm.nih.gov/pubmed/33256760
http://dx.doi.org/10.1186/s12931-020-01582-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706186/
https://www.ncbi.nlm.nih.gov/pubmed/33256760
http://dx.doi.org/10.1186/s12931-020-01582-y

Ejemplares similares